Composition

China National Intellectual Property Administration Grants New Patent Covering DUET-02, One of Three Key CpG-STAT3 Inhibitors Comprising the Duet Platform

Tuesday, September 21, 2021 - 2:00pm

NEW YORK, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, announced today that the China National Intellectual Property Administration has granted a new patent covering DUET-02, one of three key CpG-STAT3 inhibitors comprising the Duet Platform.

Key Points: 
  • The new patent covers the compound and composition, including phosphorothioated oligodeoxynucleotide, and methods of use for CpG-STAT3ASO, Duets CpG-STAT3 Antisense inhibitor.
  • Alan Horsager, Ph.D., President and Chief Executive Officer of Duet and President Immuno-Oncology for Scopus, stated, This is an important milestone for Duet Therapeutics as we continue to build our patent portfolio.
  • Dr. Horsager added, Duet continues to receive inbound inquiries regarding the Duet Platform from interested companies in Asia, including China.
  • The new patent positions Duet Therapeutics, a wholly-owned subsidiary of Scopus, to pursue opportunities arising from Chinas burgeoning biotech market.

Valued to be $108.8 Billion by 2026, Pressure Labels Slated for Robust Growth Worldwide

Tuesday, September 14, 2021 - 4:35pm

Companies:41 - Players covered include 3M Company; Avery Dennison Corporation; CCL Industries, Inc.; Constantia Flexibles Group GmbH; Coveris Holdings SA; H.B.

Key Points: 
  • Companies:41 - Players covered include 3M Company; Avery Dennison Corporation; CCL Industries, Inc.; Constantia Flexibles Group GmbH; Coveris Holdings SA; H.B.
  • Fuller Company; Henkel AG & Co. KGaA; Mondi PLC; Torraspapel S.A. (Adestor); UPM-Kymmene Corporation and Others.
  • The U.S. Market is Estimated at $25.1 Billion in 2021, While China is Forecast to Reach $18.8 Billion by 2026
    The Pressure Labels market in the U.S. is estimated at US$25.1 Billion in the year 2021.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

Lobe Sciences Provides Corporate Update to Investors and Stakeholders

Monday, September 13, 2021 - 2:43pm

Vancouver, British Columbia--(Newsfile Corp. - September 13, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to provide the following corporate update by CEO Philip Young, addressed to shareholders, investors and other stakeholders of the Company:

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - September 13, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to provide the following corporate update by CEO Philip Young, addressed to shareholders, investors and other stakeholders of the Company:
    Dear Fellow Shareholders and Psychedelic Medicine Enthusiasts,
    We are pleased to say that 2021 has been a busy and transformative year for the Company.
  • During 2021, we have made significant progress on several fronts, and completed our transition to an integrated pharmaceutical development company.
  • We believe that psychedelic based therapeutics will bring a new era of treatment for many illnesses where current therapies are insufficient or unavailable.
  • Lobe Sciences is a life sciences company focused on psychedelic medicines.

Ensysce Biosciences Reports Second Quarter 2021 Financial Results and Recent Corporate Updates

Monday, August 16, 2021 - 9:45pm

SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (Ensysce or the Company) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, today reported financial results for the second quarter of 2021 and recent corporate updates.

Key Points: 
  • SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (Ensysce or the Company) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, today reported financial results for the second quarter of 2021 and recent corporate updates.
  • Federal Grants - Funding under federal grants was $0.4 million for the second quarter of 2021 compared to $1.8 million for the second quarter of 2020.
  • G&A Expenses - General and administrative expenses were $0.4 million for the second quarter of 2021 compared to $0.3 million for the second quarter of 2020.
  • Net Loss - Net loss for the second quarter of 2021 was $1.0 million compared to $0.7 million for the same period in 2020.

Radiation Detection, Monitoring, & Safety Market by Product, Application and Region - Global Forecast to 2026 - ResearchAndMarkets.com

Monday, August 16, 2021 - 3:41pm

The "Global Radiation Detection, Monitoring, & Safety Market by Product (Detection & Monitoring (Personal Dosimeters), Composition (Gas-filled detectors, Scintillator, Solid-state detector), Application (Healthcare, Industrial Application) - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Radiation Detection, Monitoring, & Safety Market by Product (Detection & Monitoring (Personal Dosimeters), Composition (Gas-filled detectors, Scintillator, Solid-state detector), Application (Healthcare, Industrial Application) - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The radiation detection & monitoring products segment accounted for the highest growth rate in the radiation detection, monitoring, and safety market, byproduct, during the forecast period
    Based on products, the radiation detection, monitoring, and safety market is segmented into radiation detection & monitoring products and radiation safety products.
  • Based on composition, the global radiation detection & monitoring products market is segmented into gas-filled detectors, scintillators, and solid-state detectors.
  • Asia Pacific: The fastest-growing region in the Radiation detection, monitoring, and safety market
    The radiation detection, monitoring, and safety market is segmented into North America, Europe, Asia Pacific, and Rest of the World.

Global Electric Vehicle Outlook (2021 to 2030) - Europe Emerged as a Leader With 43.3% Market Share - ResearchAndMarkets.com

Thursday, August 12, 2021 - 3:34pm

Why Is It Increasingly Difficult to Grow?

Key Points: 
  • Why Is It Increasingly Difficult to Grow?
  • 5. xEV Market Overview - Europe, 2020
    6. xEV Market Overview - China, 2020
    7. xEV Market Overview - Americas, 2020
    Cost and Composition of a Typical Battery, 2020
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210812005625/en/

Ensysce Biosciences Announces Notice of Allowance from the U.S. Patent and Trademark Office for Patent Entitled “Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof”

Thursday, August 5, 2021 - 1:00pm

We are pleased to be growing our patent portfolio, said Ensysce CEO Dr. Lynn Kirkpatrick.

Key Points: 
  • We are pleased to be growing our patent portfolio, said Ensysce CEO Dr. Lynn Kirkpatrick.
  • We believe that our TAAP and MPAR platforms applied to this category of prescription drugs are unique in the industry.
  • Ensysce Biosciences, San Diego, CA is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs.
  • The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions.

Allen Press Announces Mark Kohlhase CEO

Thursday, July 22, 2021 - 7:00pm

LAWRENCE, Kan., July 22, 2021 /PRNewswire-PRWeb/ -- Allen Press announced Monday, July 19, that Mark Kohlhase has been named Chief Executive Officer, effective immediately.

Key Points: 
  • LAWRENCE, Kan., July 22, 2021 /PRNewswire-PRWeb/ -- Allen Press announced Monday, July 19, that Mark Kohlhase has been named Chief Executive Officer, effective immediately.
  • "As CEO, I believe that a servant leadership approach and a laser-like focus on our customers' well-being will help us create long-term stability for Allen Press."
  • Kohlhase will continue to focus on the core competencies of commercial printing and scholarly publishing services that are Allen Press mainstays.
  • Prior to his chief executive officer roles, Mark served as Vice President of Scholarly services at Allen Press.

Shelley Rodrigo Elected Vice President of the National Council of Teachers of English

Monday, June 14, 2021 - 1:00pm

"I am honored to be elected as NCTE's next Vice President.

Key Points: 
  • "I am honored to be elected as NCTE's next Vice President.
  • Rodrigo is the senior director of the Writing Program; associate professor in Rhetoric, Composition, and the Teaching of English; and associate writing specialist (continuing status) in the Department of English at the University of Arizona.
  • Rodrigo will take office as Vice President during the NCTE Annual Convention in November 2021.
  • The National Council of Teachers of English (NCTE) is devoted to improving the teaching and learning of English and the language arts at all levels of education.